A 200 mg dose of decaffeinated coffee cherry extract (CCE) significantly improved memory, focus and accuracy in adults (40–65) compared to placebo. Unlike caffeine in coffee beans, CCE’s polyphenols enhance neural efficiency, reducing inflammation and supporting long-term brain health. CCE brought immediate and sustained improvements, such as 80% fewer memory errors and 11% better accuracy after one hour, and 28% higher accuracy and 64% fewer false alarms after 28 days of supplementation. Remote testing proved CCE works amid daily distractions, unlike controlled lab studies. CCE’s cognitive benefits may stem from increased brain-derived neurotrophic factor (BDNF), a protein crucial for neuron growth, learning and preventing…
Newswire
Exercise: The fountain of youth for seniors – defying Big Pharma’s toxic drugs and reclaiming natural vitality Regular physical…
Russia, Ukraine and U.S. hold first trilateral talks in Abu Dhabi amid stalemate over Donbas Russia, Ukraine and the…
U.S. President Donald Trump says secret “discombobulator” disabled Venezuelan defenses during Maduro raid Trump claims a classified weapon called…
LAS VEGAS, NV — Smith & Wesson has expanded its SPEC Series line at SHOT Show 2026 with the introduction of…
A new study finds people with obesity have a distinct and pro-inflammatory community of microbes in their mouths. This “oral microbiome”…
Features
The Latest
President Trump threatens a 5% tariff on Mexican imports unless Mexico releases water owed under a 1944 treaty. The dispute centers…
Episode 36 takes us from Las Vegas to Atlanta on Southwest Airlines, and this trip was as smooth as they…
House Republicans unveil sweeping $900 billion defense bill targeting Biden-era policies, China and border security The $900 billion defense…
United States President Donald Trump has given Volodymyr Zelensky only “days” to respond to the peace plan deal. The agreement…
“Regenerate Yourself Masterclass” on BrightU: Sayer Ji introduces the “New Biology” revolution On Day 1 to 5 of “Regenerate…
Dr. Tracy Beth Hoeg, a researcher who previously investigated COVID-19 vaccine-related deaths, has been appointed acting director of the FDA’s…